Are these conclusions justified by the data presented?
The Methods stated that group 1 was offered 'immediate' empirical AT. However, in the Results section it is stated that, on an average, antibiotics were started after 1.19 days in group 1, 1.40 days in group 3 (symptom score) and 1.48 days in group 4 (dipstick urinalysis). Therefore, in none of the three groups was AT commenced immediately and was usually delayed by, at least, 1 day.
The study showed that women who were delayed antibiotic treatment for 48 h or more were likely to have a 37% longer duration of symptoms rated as moderately bad (p<0.001). This (statistically signifi cant) difference may be not considered clinically relevant. However, if AT in groups 1, 3 and 4 had commenced immediately on the day of consultation, and not the next day as the data in the results suggest, it seems likely that this difference should be increased by another day.
Interestingly, in group 1, 97% used antibiotics, whereas in groups 3 (symptom score) and 4 (dipstick urinalysis) only 90% and 80% did so, even though symptom control was similar between groups, and would have been most likely also similar if AT was commenced on the day of consultation. Therefore, preselection of patients with a positive dipstick (if nitrite or leucocytes and a trace of blood is detected in urine) for immediate AT will reduce antibiotic usage without compromise in symptom control. Only patients with a negative dipstick urinalysis should be offered delayed empiric AT, for it is also known that UTI may be present in patients with negative dipstick and these patients may profi t more from AT than from placebo. 2 The present study confi rms the usefulness of this strategy by measuring clinical outcome and antibiotic usage. A shortcoming specifi c to this study was that a group of patients preselected with dipstick and clinical scoring were not investigated, which may have further reduced the number of patients who were offered immediate AT.
I would like to suggest slightly modifi ed conclusions and recommendations, taking into consideration the cited studies:
Early empiric AT as compared with delayed AT of more 1.
than 48 h can help control symptoms faster. Therefore, if AT is indicated, it should be started immediately on the day of consultation. There is no advantage in routinely sending midstream urine samples for microbiological investigations and delay AT while waiting for the results. Immediate empiric AT should be offered only to patients 2.
with positive dipstick urinalysis and clinical scoring, in order to minimise unnecessary antibiotic usage. Because patients with negative dipstick urinalysis 3. may profi t from AT, delayed AT should be offered to those patients if symptoms persist after 48 h.
This strategy may be the best possible compromise between fast symptom control and reduction of unnecessary antibiotic use. 
